Mizuho Securities Remains a Buy on Axsome Therapeutics (AXSM)
In a report released today, Graig Suvannavejh from Mizuho Securities reiterated a Buy rating on Axsome Therapeutics (AXSM – Research Report), ...
Mizuho Securities Sticks to Its Buy Rating for Arcutis Biotherapeutics (ARQT)
In a report released today, Uy Ear from Mizuho Securities reiterated a Buy rating on Arcutis Biotherapeutics (ARQT – Research Report), with a ...
Mizuho raises Shopify stock price target to $110 from $105
Securities adjusted its price target on Shopify (NYSE:SHOP) shares, raising it from $105.00 to $110.00 while maintaining a ...
Mizuho cuts Alphabet stock price target to $230 from $235
Securities adjusted its outlook on Alphabet Inc. (NASDAQ:GOOGL), reducing the tech giant's price target from $235 to $230, ...
BioSpace6d
Gilead Passes on Option for Arcus’ Cancer Drug Despite Strong Early Data
The news comes on the heels of promising Phase I/Ib data, which point to the potential of casdatifan as a more effective ...
Travere Therapeutics, Inc. (TVTX): the Best Performing Pharma Stock So Far in 2025
We recently published a list of the 10 Best Performing Pharma Stocks So Far in 2025. In this article, we are going to take a ...
Stock Market News: S&P 500 Notches Another Record
The S&P 500 notched another record. The Dow and Nasdaq were also higher Wednesday after the stock market reacted to minutes from the Federal Reserve's January meeting.
Energy Transfer Announces $3B Senior Notes Offering
Midstream company Energy Transfer plans to use the proceeds from its $3 billion offering of senior notes to refinance ...
Diversified Energy Announces Proposed Offering of Ordinary Shares
Diversified Energy Company PLC (LSE: DEC; NYSE: DEC) (“Diversified” or the "Company"), an independent energy company focused on natural gas and liquids production, transportation, marketing and well ...